# A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70)

Study · id `cardio:ct-nct04516291` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04516291](<https://clinicaltrials.gov/study/NCT04516291>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04516291

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 286 participants.

## Technical summary

Registry record NCT04516291. Randomized; triple masking; primary purpose treatment. Start 2020-09-28 (actual); primary completion 2021-09-29 (actual). Results posted on 2022-10-04.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 286 participants (enrolled count; ClinicalTrials.gov record NCT04516291, source copy `cardio:ctgov-nct04516291-2022-10-04`, retrieved 2026-10-31)
- Started: 2020-09-28 (actual) (ClinicalTrials.gov record NCT04516291, source copy `cardio:ctgov-nct04516291-2022-10-04`, retrieved 2026-10-31)
- Primary completion: 2021-09-29 (actual) (ClinicalTrials.gov record NCT04516291, source copy `cardio:ctgov-nct04516291-2022-10-04`, retrieved 2026-10-31)
- Completion: 2021-12-06 (actual) (ClinicalTrials.gov record NCT04516291, source copy `cardio:ctgov-nct04516291-2022-10-04`, retrieved 2026-10-31)
- Results first posted: 2022-10-04 (ClinicalTrials.gov record NCT04516291, source copy `cardio:ctgov-nct04516291-2022-10-04`, retrieved 2026-10-31)
- Countries: United States; Canada; Poland (ClinicalTrials.gov record NCT04516291, source copy `cardio:ctgov-nct04516291-2022-10-04`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04516291-2022-10-04`, retrieved 2026-10-31)

## The registry's words

- Brief title: A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70)
- Condition: Dyslipidemias
- Condition: Hyperlipidemias
- Condition: Hyperlipoproteinemias
- Intervention (Drug): Vupanorsen
- Intervention (Drug): Placebo
- Lead sponsor: Pfizer
- Lead sponsor class: INDUSTRY
- Collaborator: The TIMI Study Group
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry lists this organization as the lead sponsor: Pfizer (`cardio:org-pfizer`)
- Registry lists this organization as a collaborator: The TIMI Study Group (`cardio:org-the-timi-study-group`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of Vupanorsen on Non-High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70 (`cardio:pubmed-35369705`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 2353ed1fe09ac86993a00c6ad4e691345e045b2222b54376b916b6bebf9edc00
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
